August 2025
1. HOLMEN S, Manintveld O, Damman K, Braun O, et al
   DAPAgliflozin for Renal protection in Heart Transplant recipients. Rationale and design of the randomized controlled DAPARHT trial.
   Am Heart J. 2025 Aug 19:S0002-8703(25)00300-X. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   May 2025
2. GOLD ME, Kulkarni S, Yadalam A, Patel KJ, et al
   Cardiac Allograft Vasculopathy Mediates the Relationship Between Vitamin D Deficiency and Cardiovascular Mortality Following Heart Transplantation.
   Am Heart J. 2025 May 16:S0002-8703(25)00166-8. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   August 2024
3. MEDINA CK, Barnes SG, Felker GM, Mentz RJ, et al
   Severe obesity among patients with left ventricular assist devices.
   Am Heart J. 2024;274:130-133.
   

   >> Share

   
   July 2024
4. POLSINELLI VB, Koczo A, Johnson AE, Elkayam U, et al
   Race, Hypertensive Disorders of Pregnancy and Outcomes in Peripartum Cardiomyopathy.
   Am Heart J. 2024 Jul 10:S0002-8703(24)00168-6. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   May 2023
5. SELAMET TIERNEY ES, Palaniappan L, Leonard M, Long J, et al
   Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
   Am Heart J. 2023;259:68-78.
   

   >> Share

   
   February 2023
6. ALMOND CS, Sleeper LA, Rossano JW, Bock MJ, et al
   The TEAMMATE Trial: Study Design and Rationale Tacrolimus and Everolimus Against TACROLIMUS and MMF in Pediatric Heart Transplantation Using the Major Adverse Transplant Event (MATE) Score.
   Am Heart J. 2023 Feb 22:S0002-8703(23)00038-8. doi: 10.1016/j.ahj.2023.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share